Affiliation:
1. Pavlov First Saint Petersburg State Medical University; St. George the Great Martyr City Hospital
2. Pavlov First Saint Petersburg State Medical University; St. Petersburg State University
Abstract
The article discusses classifications of medicines for gene and cell therapy. Data on medicinal products registered in Russia, as well as in the European Union countries, Great Britain, USA, and Japan is presented. The limitations on using such medicinal products were considered, including their high utilitarian cost and high risk of adverse events. The potential for increasing clinical efficacy and economic feasibility of advanced therapies (pediatrics included) has been analyzed.
Publisher
Paediatrician Publishers LLC
Reference101 articles.
1. Harding SD, Armstrong JF, Faccenda E, et al. The IUPHAR/BPS Guide to PHARMACOLOGY in 2024. Nucleic Acids Res. 2024;52(D1): D1438–D1449. doi: https://doi.org/10.1093/nar/gkad944
2. Clinical Pharmacology. Scope, Organisation, Training. Report of a WHO Study group. World Health Organ Tech Rep Ser. 1970;446:5–21.
3. CIOMS Cumulative glossary with a focus on pharmacovigilance. Geneva, Switzerland: Council for International Organizations of Medical Sciences (CIOMS); 2022. doi: https://doi.org/10.56759/ocef1297
4. Verbitskaya EV, Belousov DYu, Kolbin AS. Evidence-based medicine: new in the search for evidence. Kachestvennaya klinicheskaya praktika = Good Clinical Practice. 2023;(3):15–28. (In Russ). doi: https://doi.org/10.37489/2588-0519-2023-3-15-28
5. Fraterman S, Xie W, Wu C, et al. New drug modalities offer promise and Peril. 2023. Available online: https://www.bcg.com/publications/2023/benefits-and-risks-of-new-drug-modalities. Accessed on January 01, 2024.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献